Evidence map›Paper›PMID 25313085›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2014

Role of pyruvate kinase M2 in transcriptional regulation leading to epithelial-mesenchymal transition.

Atsushi Hamabe, Masamitsu Konno, Nobuhiro Tanuma, Hiroshi Shima, Kenta Tsunekuni, Koichi Kawamoto, Naohiro Nishida, Jun Koseki, Koshi Mimori, Noriko Gotoh and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 130 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
130citing papers in PubMed, 1 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

130 citing papers in PubMed, 1 synthesis or guideline pooled it, 237 citations in OpenAlex.

  1. Glycolytic pathway candidate markers in the prognosis of oral squamous cell carcinoma: a systematic review with meta-analysis.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2021
    Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. The Role of Sirt3 in Kidney Health and Disease.Pharmaceuticals (Basel, Switzerland) · 2025
    Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Mitochondrial CaCell reports · 2025
    Article
  20. Review

70 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Atsushi HamabeDepartments of Gastrointestinal Surgery and Frontier Science for Cancer and Chemotherapy, Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan;
Masamitsu KonnoFrontier Science for Cancer and Chemotherapy, Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan;
Nobuhiro TanumaDivision of Cancer Chemotherapy, Miyagi Cancer Center Research Institute, Sendai 981-1293, Japan;
Hiroshi ShimaDivision of Cancer Chemotherapy, Miyagi Cancer Center Research Institute, Sendai 981-1293, Japan;
Kenta TsunekuniTaiho Pharmaceutical Co., Ltd., Chiyoda-ku, Tokyo 101-0054, Japan; Taiho Pharmaceutical Co., Ltd., Chiyoda-ku, Tokyo 101-0054, Japan; Department of Cancer Profiling Discovery, Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan;
Koichi KawamotoDepartments of Gastrointestinal Surgery and Frontier Science for Cancer and Chemotherapy, Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan;
Naohiro NishidaFrontier Science for Cancer and Chemotherapy, Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan;
Jun KosekiDepartment of Cancer Profiling Discovery, Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan;
Koshi MimoriDepartment of Surgery, Kyushu University Beppu Hospital, Beppu 874-0838, Japan; and.
Noriko GotohDivision of Cancer Cell Biology, Cancer Research Institute of Kanazawa University, Kanazawa 920-1192, Japan.
Hirofumi YamamotoDepartments of Gastrointestinal Surgery and.
Yuichiro DokiDepartments of Gastrointestinal Surgery and Frontier Science for Cancer and Chemotherapy, Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan; Department of Cancer Profiling Discovery, Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan;
Masaki MoriDepartments of Gastrointestinal Surgery and Frontier Science for Cancer and Chemotherapy, Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan; Department of Cancer Profiling Discovery, Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan; mmori@gesurg.med.osaka-u.ac.jp hishii@gesurg.med.osaka-u.ac.jp.
Hideshi IshiiFrontier Science for Cancer and Chemotherapy, Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan; Department of Cancer Profiling Discovery, Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan; mmori@gesurg.med.osaka-u.ac.jp hishii@gesurg.med.osaka-u.ac.jp.
Osaka University · JPTochigi Cancer Center · JPKanazawa University · JPKyushu University Beppu Hospital · JPTaiho Pharmaceutical (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pyruvate kinase M2 (PKM2) is an alternatively spliced variant of the pyruvate kinase gene that is preferentially expressed during embryonic development and in cancer cells. PKM2 alters the final rate-limiting step of glycolysis, resulting in the cancer-specific Warburg effect (also referred to as aerobic glycolysis). Although previous reports suggest that PKM2 functions in nonmetabolic transcriptional regulation, its significance in cancer biology remains elusive. Here we report that stimulation of epithelial-mesenchymal transition (EMT) results in the nuclear translocation of PKM2 in colon cancer cells, which is pivotal in promoting EMT. Immunoprecipitation and LC-electrospray ionized TOF MS analyses revealed that EMT stimulation causes direct interaction of PKM2 in the nucleus with TGF-β-induced factor homeobox 2 (TGIF2), a transcriptional cofactor repressor of TGF-β signaling. The binding of PKM2 with TGIF2 recruits histone deacetylase 3 to the E-cadherin promoter sequence, with subsequent deacetylation of histone H3 and suppression of E-cadherin transcription. This previously unidentified finding of the molecular interaction of PKM2 in the nucleus sheds light on the significance of PKM2 expression in cancer cells.

Indexed as

Gene Expression RegulationTranscription, GeneticCell Line, TumorCell NucleusColorectal NeoplasmsDNA-Binding ProteinsDNA HelicasesEpithelial-Mesenchymal TransitionHistone Deacetylase 3Histone DeacetylasesHomeodomain ProteinsHumansNeoplasm MetastasisPromoter Regions, GeneticProtein BindingProtein TransportCHD1 protein, humanDNA-Binding ProteinsDNA HelicasesHistone Deacetylase 3Histone DeacetylasesHomeodomain ProteinsPyruvate KinaseRepressor ProteinsTGIF2 protein, humancolorectal cancerepithelial–mesenchymal transitioninvasionpyruvate kinase M2transforming growth factor-β–induced factor homeobox 2

Identifiers

PMID25313085
PMCPMC4217454
OpenAlexW2132930322

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.